News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

October 2005

Cardiac magnetic resonance imaging

By

October 28th 2005

Linking lipid parameters to coronary artery disease in women

By

October 27th 2005

Lipid parameters as predictors of coronary artery disease in women

By

October 25th 2005

Blood sugar management or cardiovascular risk reduction in type 2 diabetes? That is the question

By

October 23rd 2005

Response to insulin-resistance%u2013 oriented treatment

By

October 20th 2005

Pioglitazone decreases carotid intima-media thickness in diabetes mellitus

By

October 20th 2005

Initiating therapy for heart failure: Must ontogeny recapitulate phylogeny?

By

October 18th 2005

Carvedilol before angiotensin-converting enzyme inhibitor therapy in heart failure

By

October 15th 2005

Rate control versus rhythm control in atrial fibrillation

By

October 13th 2005

Proarrhythmic events in atrial fibrillation: A multivariate analysis of the AFFIRM study

By

October 9th 2005

The GEMINI trial: The role of carvedilol in treating hypertensive patients with diabetes

By

October 9th 2005

Carvedilol versus metoprolol in diabetic hypertensive patients

By

October 5th 2005

Clinical Trials and Community Programs at the ABC

By

October 4th 2005

Aspirin dose less than 100 mg associated with lowest risk of bleeding

By

October 2nd 2005

Fondaparinux safer than standard antithrombotic therapy in ACS

By

October 1st 2005

Trending on HCPLive

How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD

Biologic Selection in Severe Asthma: Biomarkers, Comorbidities, When to Switch

What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata

Clofutriben Phase 2a Data Show Cardiometabolic Benefits in Type 2 Diabetes

FDA Approves Lebrikizumab 8-Week Maintenance Dosing in Atopic Dermatitis